Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/13/2003 | US6562014 Device and method for enhancing transdermal flux of agents being sampled |
05/13/2003 | US6561989 Thin lance and test sensor having same |
05/13/2003 | US6561978 Devices and methods for frequent measurement of an analyte present in a biological system |
05/13/2003 | US6561010 Apparatus and method for fluid analysis |
05/13/2003 | CA2105998C Human pf4a receptors and their use |
05/13/2003 | CA2105979C Monoclonal antibody against lps core |
05/13/2003 | CA2086131C Anti-human ige monoclonal antibodies |
05/13/2003 | CA2055095C Column agglutination assay and device |
05/09/2003 | CA2411537A1 Gene detecting method and test kit |
05/09/2003 | CA2411476A1 Functional assay for agonist activation of receptors |
05/09/2003 | CA2411292A1 Hydrogen sensor |
05/09/2003 | CA2390983A1 Antibody testing method and antigen microarray |
05/08/2003 | WO2003038842A1 Composite particle containing superparamagnetic iron oxide |
05/08/2003 | WO2003038728A2 A computer system and method using mass spectrometry data and a protein database for identifying unknown proteins |
05/08/2003 | WO2003038726A2 A method for epigenetic knowledge generation |
05/08/2003 | WO2003038724A2 Methods and apparatus for protein sequence analysis |
05/08/2003 | WO2003038685A2 Method for monitoring a public water treatment system |
05/08/2003 | WO2003038444A2 Biomarkers of liver function |
05/08/2003 | WO2003038443A2 Noe-nmr based methods for the identifycation of compounds which can bind to membrane receptors |
05/08/2003 | WO2003038442A2 Processes for producing optimized pharmacophores |
05/08/2003 | WO2003038441A2 Screening methods based on cited family proteins |
05/08/2003 | WO2003038440A2 Chemokine binding molecules |
05/08/2003 | WO2003038439A2 Functional identification of targets on tissues and cells |
05/08/2003 | WO2003038438A1 Method for comparing two protein states |
05/08/2003 | WO2003038437A2 Screening method for active agents which influence nerve cells |
05/08/2003 | WO2003038436A2 Microfluidic ser(r)s detection |
05/08/2003 | WO2003038435A1 Method of analysing the conformation of a peptide having an affinity for target substances and the use thereof in the analysis of lipoproteins |
05/08/2003 | WO2003038434A2 Serological assay for neospora caninum |
05/08/2003 | WO2003038433A1 Test apparatus |
05/08/2003 | WO2003038432A1 Chi square tests for gene expression |
05/08/2003 | WO2003038431A1 Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells |
05/08/2003 | WO2003038430A1 Screening method |
05/08/2003 | WO2003038429A1 Method of examining condition of active oxygen radical in human body based on luminescence |
05/08/2003 | WO2003038428A1 Device for measuring the oxidizable carbon of a liquid and a method for the use thereof |
05/08/2003 | WO2003038423A2 Sensor assembly |
05/08/2003 | WO2003038421A1 A system and method for detecting hydride gases at low concentrations and in the presence of varying humidity levels |
05/08/2003 | WO2003038420A1 Biosensor circuit and sensor array consisting of a plurality of said biosensor circuits and biosensor array |
05/08/2003 | WO2003038411A1 A method of determining the content of s02 in a beverage product |
05/08/2003 | WO2003038406A1 A sampling valve |
05/08/2003 | WO2003038404A2 In vitro metabolic engineering on microscale devices |
05/08/2003 | WO2003038402A2 A peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis |
05/08/2003 | WO2003038401A2 Semiconductor nanocrystal-based cellular imaging |
05/08/2003 | WO2003038400A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 54394 |
05/08/2003 | WO2003038399A2 Chemiluminescent acridinium compounds and their use in an assay to detect analytes |
05/08/2003 | WO2003038397A2 Assay |
05/08/2003 | WO2003038394A2 Device and method for determining the quality a medium, particularly of a lubricant and/or coolant |
05/08/2003 | WO2003038131A1 Biocatalytic solgel microarrays |
05/08/2003 | WO2003038130A2 Therapeutics and diagnostics for disorders of erythropoiesis |
05/08/2003 | WO2003038128A1 Methods and compositions for the treatment and diagnosis of pain disorders using 57749 |
05/08/2003 | WO2003038126A1 Probe beads for affinity reaction and detection system |
05/08/2003 | WO2003038124A1 Use of cbg gene as genetic marker of hypercortisolemia and related pathologies |
05/08/2003 | WO2003038121A2 Method for the detection of cytosine methylation in immobilised dna samples |
05/08/2003 | WO2003038114A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 86604 |
05/08/2003 | WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
05/08/2003 | WO2003038110A2 7118, a human arginine n-methyltransferase family member and uses therefor |
05/08/2003 | WO2003038096A1 Receptor for angiogenesis inhibitor and method of screening angiogenesis inhibitor |
05/08/2003 | WO2003038091A1 Oligonucleotide sequences free from mishybridization and method of designing the same |
05/08/2003 | WO2003038089A1 Probe solutin compositions, reactive chip using the same and process for the production thereof |
05/08/2003 | WO2003038088A1 Molecular diagnosis method for multiple myeloma |
05/08/2003 | WO2003038087A1 DR5 GENE PROMOTER AND Siah-1 GENE PROMOTER |
05/08/2003 | WO2003038086A1 Soft ionization device and applications thereof |
05/08/2003 | WO2003038080A1 Crystal structure of phosphodiesterase 5 and use thereof |
05/08/2003 | WO2003038071A1 Detection of haematopoietic stem cells and progeny and uses thereof |
05/08/2003 | WO2003038056A2 Methods for inhibiting lentivirus replication |
05/08/2003 | WO2003038054A2 Structure-based design and synthesis of fgf inhibitors and fgf modulator compounds |
05/08/2003 | WO2003038052A2 Nucleic acid-associated proteins |
05/08/2003 | WO2003038039A2 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
05/08/2003 | WO2003038037A2 Glycogen synthase kinase function in endothelial cells |
05/08/2003 | WO2003038033A2 Protein and peptide nanoarrays |
05/08/2003 | WO2003038030A1 Device with recessed tracks for forming a cellular network |
05/08/2003 | WO2003037930A1 Novel human n-methyl-d-asparatate (nmda) glutamate receptor polypeptide and gene encoding the same |
05/08/2003 | WO2003037926A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
05/08/2003 | WO2003037924A1 Aequorin as a reporter gene in yeast |
05/08/2003 | WO2003037923A1 Aequorin as a growth marker in yeast |
05/08/2003 | WO2003037921A1 Immunointeractive molecules and uses thereof |
05/08/2003 | WO2003037491A2 Microfluidic micromixer |
05/08/2003 | WO2003037369A1 A rapid serological test for paratuberculosis using fluorescence polarization technology |
05/08/2003 | WO2003037367A2 New bacterium causing poultry disease and vaccine derived thereof |
05/08/2003 | WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
05/08/2003 | WO2003037358A1 A pharmaceutical composition having cholagogic and litholytic effect and its preparation method |
05/08/2003 | WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors |
05/08/2003 | WO2003037326A1 Solid phase synthesis of chemical libraries |
05/08/2003 | WO2003037261A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
05/08/2003 | WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
05/08/2003 | WO2003037257A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
05/08/2003 | WO2003037255A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319 |
05/08/2003 | WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
05/08/2003 | WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
05/08/2003 | WO2003037250A2 Matrix methods for analyzing properties of botanical samples |
05/08/2003 | WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy |
05/08/2003 | WO2003037167A2 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor |
05/08/2003 | WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
05/08/2003 | WO2003037080A1 Nonhuman model animal of systemic lupus erythematosus |
05/08/2003 | WO2003037079A1 NONHUMAN MODEL ANIMAL OF Th2-MEDIATED HYPERIMMUNE RESPONSE |
05/08/2003 | WO2003025217A8 Prognostic method |
05/08/2003 | WO2003025138A3 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
05/08/2003 | WO2003023404A8 A method of diagnosis and treatment and agents useful for same |
05/08/2003 | WO2003020891A3 Single nucleotide amplification and detection by polymerase |
05/08/2003 | WO2003019186A3 Assay for identifying ion channel modulators |
05/08/2003 | WO2003014322A3 Proteins associated with cell growth, differentiation, and death |